V. Frascogna
About
In The Last Decade
V. Frascogna
13 papers receiving 394 citations
Peers
Comparison fields: 5 of 67
- Oncology 223
- Molecular Biology 205
- Cell Biology 144
- Cancer Research 81
- Pulmonary and Respiratory Medicine 49
Countries citing papers authored by V. Frascogna
This map shows the geographic impact of V. Frascogna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Frascogna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Frascogna more than expected).
Fields of papers citing papers by V. Frascogna
This network shows the impact of papers produced by V. Frascogna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Frascogna. The network helps show where V. Frascogna may publish in the future.
Co-authorship network of co-authors of V. Frascogna
This figure shows the co-authorship network connecting the top 25 collaborators of V. Frascogna. A scholar is included among the top collaborators of V. Frascogna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Frascogna. V. Frascogna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 45 | |
| 3 | 73 | |
| 4 | 62 | |
| 5 | Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model. | 28 |
| 6 | 28 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 38 | |
| 10 | 44 | |
| 11 | 1 | |
| 12 | Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo. | 54 |
| 13 | The olivacine S16020 enhances the antitumor effect of ionizing radiation without increasing radio-induced mucositis. | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.